Chronic Low Back Pain, Opioid Taper, and a Skeptical Patient
A 52-year-old woman with 6 years of chronic nonspecific low back pain is on oxycodone 10 mg four times daily and gabapentin 600 mg three times daily. Her pain is 7/10, function is poor, and she has gained 12 kg. She has tried physical therapy twice 'without help.' She is fearful of worsening pain if opioids are reduced and skeptical of 'alternative stuff.' She has no red flags, no prior surgery, and imaging shows only mild degenerative changes. She asks you to 'just get the dose increased' and says mindfulness and yoga are 'not real medicine.'
1. How do you respond to the request for a dose increase while honoring her goals and maintaining the therapeutic alliance?
Read the worked answer
Start by validating her experience and clarifying her actual goals (sleep, walking, work, grandkids) rather than arguing about the dose. Explain honestly that escalating opioids for chronic nonspecific back pain has limited long-term benefit and real harms (tolerance, hyperalgesia, weight gain, function decline), and that guidelines favor a gradual, collaborative taper paired with active nonpharmacologic care. Do not frame it as 'no' but as 'a different and likely better plan.'
Use shared decision-making: acknowledge her fear of pain worsening, explain that a slow taper is done with her input and monitoring, and that active therapies are added first so she has tools before reduction. Avoid dismissing her skepticism; instead invite a time-limited trial with measurable goals (e.g., function and pain at 8 weeks) so 'does it work for me' becomes an empirical question.
2. Design a pragmatic initial integrative plan and specify how you would measure whether it is working.
Read the worked answer
Combine evidence-supported elements for chronic low back pain: (1) structured exercise/PT with a graded activity focus, restarted with a different approach than prior failed attempts; (2) a mind-body component - mindfulness-based stress reduction or yoga - offered as a time-limited trial with a clinician who can address her skepticism; (3) consider acupuncture as an adjunct for short-term pain relief if she is open; (4) address sleep, weight, and mood, which amplify pain; (5) coordinate a slow, agreed opioid taper with the prescriber, not abrupt. Gabapentin should be reviewed for benefit versus sedation/weight.
Measure with concrete anchors: a functional outcome (e.g., Oswestry or PROMIS function), pain and sleep ratings, steps or activity, and opioid dose over time. Set a review at 6-8 weeks. If a component shows no benefit by then, stop it - this respects her skepticism and avoids piling on ineffective care.